Quench Bio

Quench Bio is a biotechnology company based in Cambridge, Massachusetts. The company is small, with a team of six employees. Quench Bio specializes in the development of novel medicines for the treatment of severe inflammatory diseases. Their research focuses on leveraging insights into gasdermin biology and innate immunity. Quench Bio's lead compounds are designed to target and inhibit Gasdermin D, a protein that plays a crucial role in inflammatory processes. The company's unique approach centers on inhibiting Gasdermin D, which is involved in pyroptosis and NETosis, pathways responsible for the release of inflammatory mediators. By targeting this protein, Quench Bio aims to effectively control inflammation and provide therapeutic benefits for patients with severe inflammatory diseases. For more information about Quench Bio and its innovative approaches to treating inflammatory diseases, please visit their website at quenchbio.com.